medigraphic.com
Asociación Mexicana de Gastroenterología

2006, Number 1

<< Back Next >>

Rev Gastroenterol Mex 2006; 71 (1)

Minimal hepatic encephalopathy: characteristics, diagnosis and clinical implications

Torre DA, Guerrero-Hernández I, Uribe M

Language: Spanish
References: 53
Page: 63-70
PDF size: 84.68 Kb.


ABSTRACT

The term minimal hepatic encephalopathy (MHE) refers to the subtle changes in cognitive function, electrophysiological parameters, cerebral neurochemical/neurotransmitter homeostasis, cerebral blood flow, metabolism, and fluid homeostasis that can be observed in patients with cirrhosis who have no clinical evidence of hepatic encephalopathy; the prevalence is as high as 84% in patients with hepatic cirrhosis. This cirrhosis complication is generally not perceived by physician, and diagnosis can only be made by neuropsychological tests and other especial measurements like evoked potentials and image studies like positron emission tomography. Diagnosis of minimal hepatic encephalopathy may have prognostic and therapeutic implications in cirrhotic patients. The present review pretends to explore the clinic, therapeutic, diagnosis and prognostic aspects of this complication.


REFERENCES

  1. Quero JC, Schalm S. Subclinical hepatic encephalopathy. Semin Live Dis 1996; 16: 321-8.

  2. Dhiman RH, Saraswat VA, Verma M, et al. Figure connection test: a universal test for assessment of mental state. J Gastroenterol Hepatol 1995; 10: 14-23.

  3. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, nonshunted patients with cirrhosis. J Hepatol 1986; 3: 75-82.

  4. Schomerus H, Hamster W. Quality of life in cirrhosis with minimal hepatic encephalopathy. Metab Brain Dis 2001; 16: 37-41.

  5. Watanabe A. Cerebral changes in hepatic encephalopathy. J Gastroenterol Hepatol 1998; 13: 752-60.

  6. Watanabe A, Tuchida T, Yata Y, et al. Evaluation of neuropsychological function in patients with liver cirrhosis with special reference to their driving ability. Metab Brain Dis 1995; 10: 239-48.

  7. Das A, Dhiman RK, Saraswat VA, et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 2001; 16: 531-5.

  8. Córdoba J, Sanpedro F, Alonso J, et al. 1H magnetic resonance in the study of hepatic encephalopathy in humans. Metab Brain Dis 2002; 17: 415-29.

  9. Ferenci P, Loockwood A, Mullen K, et al. Hepatic encephalopahty definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congress of Gastroenterology, Vienna 1998. Hepatology 2002; 35: 716-21.

  10. Joebges EM, Heidemann M, Schimke N, et al. Bradykinesia in minimal hepatic encephalopathy is due to disturbances in movement initiation. J Hepatol 2003; 38: 273-80.

  11. Yang SS, Wu CH, Chiang TR, et al. Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests. Hepatology 1998; 27: 357-61.

  12. Ananya D, Radha KD, Vivek AS, et al. Prevalence and natural history of subclinical hepatic encephalopahty in cirrhosis. J of Gastroenterol Hepatol 2001; 16: 531-5.

  13. Zeneroli M, Ciono G, Ventura P, et al. Interindividual variability of the number connection test. J Hepatol 1992; 16: 263-4.

  14. Weissenborn K, Ruckert N, Hecker H, et al. The number connection test A and B interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol 1998; 28: 646-53.

  15. Conn HO. Trailmaking and number connection tests in the assessment of mental state in portal systemic encephalopathy. Am J Dig Dis 1977; 22: 541-50.

  16. Weissenborn K, Ennen JC, Rückert N, et al. Neuropsychological characterization of hepatic encephaloapthy. J Hepatol 2001; 34: 768-73.

  17. Amodio P, Marchett P, Del Piccolo F, et al. Study on the Sternberg paradigm in cirrhotic patients without hepatic encephalopathy. Metab Brain Dis 1998; 13: 159-72.

  18. Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low grade hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995; 22: 101-10.

  19. Kircheis G, Wettstein M, Timmermann L, et al. Critical flicker frequency for quantification of low grade hepatic encephalopathy. Hepatology 2002; 35: 357-66.

  20. Niedermeyer E. Metabolic central nervous system disorders. In: Niedermeyer E, Lopes Da Silva F (eds.). Electroencephalography. Basis Priciples, Clinical Applications, and Related Fields, 4th ed. Baltimore: Williams and Wilkins; 1994, p. 416-31.

  21. Kullmann F, Hollerbach S, Holstege A, et al. Subclinical hepatic encephalopathy: the diagnostic value of evoked potentials. J Hepatol 1995; 22: 101-10.

  22. Amodio P, Marchetti P, Del Piccolo F, et al. Spectral versus visual EEG analysis in mild hepatic encephalopathy. Clin Neurophysiol 1999; 110: 1334.

  23. Amodio P, Del Piccolo F, Petteno E, et al. Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients. J Hepatol 2001; 35: 37-45.

  24. Menhdiratta MM, Sood GK, Sarin SK, et al. Comparative evaluation of visual, somatosensory, and auditory evoked potentials in the detection of subclinical hepatic encephalopathy in patients with nonalcoholic cirrhosis. Am J Gastroenterol 1990; 85: 799-803.

  25. Suzuki C, Osaki I, Tanosaki M, et al. Peripheral and central conduction abnormalities in diabetes mellitus. Neurology 2000; 54: 1932-7.

  26. Virtaniemi J, Kuusisto J, Karjalainen L, et al. Improvement of metabolic control does not normalize auditory brainstem latencies in subjects with insulin-dependent diabetes mellitus. Am J Otolaryngol 1995; 16: 172-6.

  27. Saxena N, Bathia M, Joshi YK, et al. Auditory P300 event related potentials and number connection test for the diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis of liver. A follow up study. J Gastroenterol Hepatol 2001; 16: 322-7.

  28. Jover R, Compañy L, Gutiérrez A, et al. Minimal hepatic encephalopathy and extrapyramidal signs in patients with cirrhosis. Am J Gastroenterol 2003; 98: 1599-604.

  29. Ross BD, Danielsen ER, Blum S. Proton magnetic resonance spectroscopy: the new gold standard for diagnosis of clinical and subclinical hepatic encephalopathy? Dig Dis 1996; 14(Suppl 1): 30-9.

  30. Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR-specroscopic abnormalities: Radiology 1994; 193: 457-63.

  31. Mechtcheriakov S, Shocke M, Kugener A, et al. Chemical shoft magnetic resonance spectroscopy of congulate grey matter in patients with minimal hepatic encephalopathy. Neuroradiology 2005; 47: 27-34.

  32. Weissenborn K, Heidenreich S, Giewekemeyer K, et al. Memory function in early hepatic encephalopathy. J of Hepatol 2003; 39: 320-5.

  33. Dam M, Burra P, Tedaschi U, et al. Regional cerebral blood flow changes in patients with cirrhosis assesses with 99mTc-HM-PAQ single photon emission computed tomography: effect of liver transplantation. J Hepatol 1998; 29: 78-84.

  34. Catafau AM, Kuliesevsky J, Berná L, et al. Relationship between cerebral perfusion in frontal-limbic-basal ganglia circuits and neuropsychologic impairment in patients with subclinical hepatic encephalopathy. J Nucl Med 2000; 41: 405-10.

  35. Posner MI. Petersen SE. The attention system of the human brain. Annu Rev Neurosci 1990; 13: 25-42.

  36. Posner MI. Attention in cognitive neuroscience: an overview: the cognitive neuroscience. In: Gazzaniga MS (ed.). Cambridge Massachusetts: MIT press; 1995, p. 615-24.

  37. Trzepacz PT, Tarter RE, Shah A, et al. SPECT scan and cognitive findigns in subclinical hepatic encephalopathy. J Neuropsychiatry Clin Neurosci 1994; 6: 170-5.

  38. Lockwood AH, Murphy BW, Donnelly KZ, et al. Positron emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy. Hepatology 1993; 18: 1061-8.

  39. Groeneweg M, Quero JC, De Bruijin I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.

  40. Ortiz M, Jacas C, Córdoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 2005; 42: S45-53.

  41. Lockwood AH, Yap EW, Wong WH. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 11: 337-41.

  42. Cordoba J, Alonso J, Rovira A, et al. The development of low grade oedema in cirrhosis is supported by the evolution of (1) H-magnetic resonance abnormalities after liver transplantation. J Hepatol 2001; 35: 598-604.

  43. Loockwood AH, Yap EW, Rhoades HM, et al. Altered cerebral blood floow and glucose metabolism in patients with liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991; 22: 331-6.

  44. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997; 337: 473-9.

  45. Jia L, Zhang MH. Comparison of probiotics and lactulose in the treatment of minimal hepatic encephalopathy in rats. World J Gastroenterol 2005; 11 (6); 908-911.

  46. Solga SF. Probiotics can treat hepatic encephalopathy: Med Hypotheses 2003; 34: 768-73.

  47. Liu Q, Ping Duan Z, Kang Ha S, et al. Synbiotic modulation of gut flora: Effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9.

  48. de Bruijin KM, Blendis LM, Zilm DH, et al. Effect of dietary protein manipulation in subclinical portal-systemic encephalopathy. Gut 1983; 24: 53-60.

  49. Egberts EH, Schomerus H, Hamster W, et al. Branched chain amino acids in the treatment of latent protosystemic encephalopathy. A double-blind placebo-controlled corssover study. Gastroenterology 1985; 88: 887-95.

  50. Gooday R, Hayes PC, Bzeizi K, et al. Benzodiacepine receptor antagonism improves reaction time in latent hepatic encephalopathy. Psychopharmacology 1995; 119: 295-8.

  51. Yen CL, Liaw YF. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy. Hepato-Gastroenterol 1990; 37: 332-4.

  52. Romero-Gómez M, Grande L, Camacho I, et al. Altered response to oral glutamine challange as pornostic factor for overt episodes in patients with minimal hepatic encephalopathy. J Hepatol 2002; 37: 781-7.

  53. Bustamante J, Rimola A, Ventura P, et al. Prognostic significance of hepatic encephalopathy in patients with cirrosis. J Hepatol 1999; 30: 890-95.




2020     |     www.medigraphic.com